Detalhe da pesquisa
1.
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
Cell
; 175(4): 1014-1030.e19, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343900
2.
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
Cell
; 175(5): 1443, 2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445041
3.
MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Nature
; 574(7780): 696-701, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31645760
4.
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads.
Proc Natl Acad Sci U S A
; 118(24)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099555
5.
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Nature
; 515(7528): 577-81, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428507
6.
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Nature
; 482(7385): 400-4, 2012 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318521
7.
Improvement of tumor neoantigen detection by high field asymmetric waveform ion mobility mass spectrometry.
Cancer Immunol Res
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768391
8.
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.
Cancer Immunol Res
; 5(2): 106-117, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073774
9.
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.
Cell Rep
; 17(1): 249-260, 2016 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27681435
10.
Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
J Exp Med
; 208(10): 1989-2003, 2011 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21930769